NCT04643249View on ClinicalTrials.gov

Drug-drug Interaction Study of KL1333 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

December 17, 2020

Study Completion Date

December 17, 2020

Conditions

Mitochondrial Disease

Interventions

DRUG

KL1333

Tablet

DRUG

Flurbiprofen

Tablet

DRUG

Dextromethorphan

Syrap

DRUG

Bupropion

Tablet

DRUG

Midazolam injection

solution for injection

DRUG

Omeprazole

Capsule

DRUG

Caffeine

Tablet or capsule

DRUG

Repaglinide

Tablet

Trial Locations (1)

Unknown

Volunteer recruitment center Covance Leeds Covance Leeds, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abliva AB

INDUSTRY